Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urogenital Neoplasms 1Small Cell Lung Carcinoma 1Respiratory Syncytial Virus Infections 1Prostatic Neoplasms 1Lung Neoplasms 1Genital Neoplasms, Male 1Carcinoma, Non-Small-Cell Lung 1

Interventions

padeliporfin 2Paclitaxel 2sipuleucel-T 1pembrolizumab 1luprolide acetate gel depot 1ixabepilone 1Therapeutics 1Suspensions 1Powders 1Pluvicto 1Nivolumab 1Leuprolide 1Ipilimumab 1Imatinib Mesylate 1Gemcitabine 1Cisplatin 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Genital Neoplasms, Male × Suspensions × Clear all
NCT04221828 2022-03-29

Trial of NanoPac Focal Therapy for Prostate Cancer

NanOlogy, LLC

Phase 2 Terminated
1 enrolled 5 charts
Genitourinary

Genital Neoplasms, Male, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡